Stephen J Greene Selected Research

Natriuretic Peptides

2/2024	Use of natriuretic peptides and echocardiography for diagnosing heart failure.
7/2023	Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society.
1/2017	Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.
8/2016	Natriuretic peptide-guided management in heart failure.
12/2015	Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
3/2015	The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.
1/2015	Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
5/2014	Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial.
12/2013	Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
2/2013	Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Greene Research Topics

Disease

180	Heart Failure 05/2024 - 09/2012
7	Type 2 Diabetes Mellitus (MODY) 02/2024 - 12/2019
7	Hypotension (Low Blood Pressure) 01/2022 - 09/2012
6	Cardiomyopathies (Cardiomyopathy) 04/2024 - 01/2017
6	Atrial Fibrillation 01/2023 - 12/2013
6	Myocardial Infarction 12/2020 - 11/2013
6	Diabetes Mellitus 01/2019 - 12/2012
4	COVID-19 05/2024 - 01/2022
4	Chronic Renal Insufficiency 01/2023 - 06/2014
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 07/2014
4	Stroke (Strokes) 01/2022 - 11/2013
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 11/2020
3	Hyperkalemia 01/2022 - 03/2013
3	Dyspnea (Shortness of Breath) 11/2021 - 01/2016
3	Acute Coronary Syndrome 11/2020 - 11/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2019 - 07/2016
3	Renal Insufficiency (Renal Failure) 01/2019 - 02/2013
2	Inflammation (Inflammations) 05/2024 - 01/2017
2	Infections 05/2024 - 01/2023
2	Weight Loss (Weight Reduction) 04/2024 - 01/2021
2	Cardio-Renal Syndrome 01/2023 - 03/2013
2	Disease Progression 01/2022 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 05/2020
2	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2018 - 04/2016
2	Systolic Heart Failure 10/2016 - 09/2014
2	Body Weight (Weight, Body) 12/2014 - 12/2013
1	Obesity 03/2024
1	Pericardial Effusion 11/2023
1	Spinal Stenosis (Stenosis, Spinal) 11/2023
1	Carpal Tunnel Syndrome 11/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2022
1	Frailty 01/2022
1	Weight Gain 11/2021
1	Edema (Dropsy) 11/2021

Drug/Important Bio-Agent (IBA)

21	DiureticsIBA 05/2024 - 12/2012
18	SodiumIBA 04/2024 - 02/2013
16	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024 - 12/2012
16	Tolvaptan FDA Link 01/2018 - 11/2012
15	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2018
15	Vasopressins (Vasopressin)IBA 01/2018 - 11/2012
14	Angiotensin Receptor AntagonistsIBA 01/2024 - 12/2012
14	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2023 - 01/2015
12	Torsemide (Demadex)FDA LinkGeneric 05/2024 - 01/2018
11	Furosemide (Lasix)FDA LinkGeneric 05/2024 - 01/2019
11	sacubitril and valsartan sodium hydrate drug combinationIBA 05/2024 - 01/2018
10	Neprilysin (Neutral Endopeptidase)IBA 04/2024 - 01/2018
10	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2024 - 01/2018
10	Natriuretic PeptidesIBA 02/2024 - 02/2013
8	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2013
8	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 09/2014
7	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2024 - 12/2020
6	SymportersIBA 04/2024 - 12/2020
6	Sodium-Glucose Transport ProteinsIBA 03/2024 - 12/2019
5	vericiguatIBA 04/2023 - 12/2015
5	aliskiren FDA Link 01/2018 - 03/2013
4	CreatinineIBA 04/2024 - 05/2014
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2023 - 01/2015
4	TroponinIBA 11/2023 - 01/2018
3	dapagliflozinIBA 01/2023 - 11/2020
3	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 01/2015
3	Digoxin (Digitek)FDA LinkGeneric 01/2018 - 12/2012
3	Soluble Guanylyl CyclaseIBA 12/2015 - 09/2012
2	AnticoagulantsIBA 01/2023 - 11/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 11/2014
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2022
2	Renin InhibitorsIBA 01/2018 - 10/2013
2	ReninIBA 01/2018 - 11/2017
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2016 - 02/2016
2	Antidiuretic Hormone Receptor AntagonistsIBA 01/2015 - 05/2014
2	Hemoglobins (Hemoglobin)IBA 12/2014 - 05/2014
2	Warfarin (Coumadin)FDA LinkGeneric 06/2014 - 11/2013
1	SolutionsIBA 03/2024
1	Acetazolamide (Diamox)FDA LinkGeneric 02/2024
1	Amyloid (Amyloid Fibrils)IBA 11/2023
1	EnzymesIBA 11/2023
1	Prealbumin (Transthyretin)IBA 11/2023
1	omecamtiv mecarbilIBA 10/2023
1	empagliflozinIBA 01/2023
1	Anti-Arrhythmia AgentsIBA 01/2023
1	Metolazone (Diulo)FDA LinkGeneric 11/2021
1	Bumetanide (Bumex)FDA LinkGeneric 11/2021
1	Sodium-Glucose Transporter 1IBA 01/2021

Therapy/Procedure

86	Therapeutics 04/2024 - 12/2012
8	Patient Readmission 10/2023 - 03/2013
3	Contraindications 01/2023 - 01/2019
3	Secondary Prevention 10/2022 - 07/2016
3	Length of Stay 01/2022 - 10/2015
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 12/2022 - 01/2022
1	Defibrillators (Defibrillator) 01/2024
1	Cardiac Resynchronization Therapy 01/2024
1	Episode of Care 01/2024
1	Cardiac Rehabilitation 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Hospice Care (Care, Bereavement) 01/2023
1	Heart-Assist Devices 01/2021